Henry Schein (NASDAQ:HSIC) Stock Breaks Above 50-Day Moving Average – Time to Sell?

Henry Schein, Inc. (NASDAQ:HSIC) passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $86.49 and traded as high as $87.28. Henry Schein shares last traded at $86.62, with a volume of 2,501,802 shares traded.

Wall Street Analysts Forecast Growth

HSIC has been the topic of several recent research reports. Leerink Partners set a $92.00 price target on shares of Henry Schein and gave the stock a “market perform” rating in a research report on Wednesday, October 14th. Stifel Nicolaus set a $95.00 price objective on Henry Schein in a research report on Wednesday, August 5th. BTIG Research raised their price objective on Henry Schein from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. Barclays restated an “overweight” rating and issued a $100.00 price objective (up from $86.00) on shares of Henry Schein in a research note on Thursday, August 6th. Finally, BMO Capital Markets started coverage on shares of Henry Schein in a research report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 target price on the stock. Nine equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $93.27.

Henry Schein Stock Performance

The company has a market capitalization of $9.65 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 1.53 and a beta of 0.84. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.73. The stock has a 50-day moving average price of $86.49 and a 200-day moving average price of $81.15.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 4th. The company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.24 by $0.03. The firm had revenue of $3.46 billion for the quarter, compared to analyst estimates of $3.37 billion. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm earned $1.10 EPS. As a group, analysts forecast that Henry Schein, Inc. will post 5.36 earnings per share for the current year.

Institutional Trading of Henry Schein

A number of institutional investors have recently added to or reduced their stakes in HSIC. Southpoint Capital Advisors LP raised its position in shares of Henry Schein by 28.0% in the 1st quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company’s stock worth $235,840,000 after acquiring an additional 700,000 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Henry Schein by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,873,004 shares of the company’s stock valued at $211,734,000 after purchasing an additional 56,687 shares in the last quarter. M.D. Sass LLC grew its holdings in Henry Schein by 2.9% during the 1st quarter. M.D. Sass LLC now owns 1,273,316 shares of the company’s stock valued at $93,843,000 after purchasing an additional 35,443 shares during the last quarter. Bank of America Corp DE increased its stake in Henry Schein by 5.9% in the 1st quarter. Bank of America Corp DE now owns 1,221,585 shares of the company’s stock worth $90,031,000 after buying an additional 68,593 shares during the period. Finally, Defilade Capital Management L.P. lifted its holdings in shares of Henry Schein by 94.8% in the 1st quarter. Defilade Capital Management L.P. now owns 624,037 shares of the company’s stock worth $45,992,000 after buying an additional 303,615 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc (NASDAQ: HSIC) is a global provider of healthcare products and services serving dental and medical professionals, as well as veterinary practices and laboratories. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used in clinical and practice-management settings.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support clinical workflows, electronic health records, practice management, procurement, equipment installation, and technical support.